Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Esta Multi Usaha Tbk. (ESTA) vs Indofarma Tbk. (INAF) Price & Performance

Esta Multi Usaha Tbk.Trade
Indofarma Tbk.Trade

Price performance (Past 24H)

Key statistics

Esta Multi Usaha Tbk. vs Indofarma Tbk. — how do they compare? Esta Multi Usaha Tbk. trades at Rp172 (market cap 422.01B, 3.9M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Esta Multi Usaha Tbk. and Indofarma Tbk. are close in size by market cap. Which is the better fit depends on your goals.

ESTAINAF
Market Cap
422.01B390.51B
Volume
3.9M
Lot
39.02K
Turnover
691.55M
Average Price
177.25
Value
691.55M
Indicative Equilibrium Price
172
Indicative Equilibrium Volume
235

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ESTA
View details
INAF
View details

About Esta Multi Usaha Tbk.

PT Esta Multi Usaha Tbk (the “Company”) was established under the name PT Esta Asri Propertindo, based on Notarial Deed No. 34 dated September 30, 2011 of Kun Hidayat, S.H., notary in Jakarta. The Company started its commercial operations in 2012. Until 2017, the Company only did real estate leasing business activities. In 2018, the Company started its hospitality business activities.Whereas in 2019, the Company commenced vehicle rental business activities without option rights.

Read more on ESTA

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF